find macnutrients % distbution for all kidney PARAMETERS
Reading File
Finding Sources
Finding Sources
Searching the Web
macronutrient distribution chronic kidney disease CKD protein carbohydrate fat percentage recommendations KDOQI
Finding Sources
Finding Sources
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC10756934
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Searching the Web
KDOQI 2020 nutrition guidelines CKD macronutrient protein carbohydrate fat percentage hemodialysis peritoneal dialysis nephrotic syndrome
Reading Web Page
https://dietitiansondemand.com/summarizing-updates-to-the-kd…
Finding Sources
Now I have comprehensive data from both the medical textbooks and KDOQI guidelines. Let me compile the full answer.
Macronutrient % Distribution for All Kidney Disease Parameters
Below is a comprehensive breakdown organized by kidney condition/parameter, based on KDOQI 2020 Clinical Practice Guidelines, KDIGO guidelines, Brenner & Rector's The Kidney, and Comprehensive Clinical Nephrology (7th ed).
1. Energy (Caloric) Requirements - Universal for CKD
| Parameter | Recommendation |
|---|---|
| Total energy intake | 30-35 kcal/kg IBW/day for all CKD stages |
| CKD Stage 1-5 (non-dialysis) | 25-35 kcal/kg/day (adjusted for age, sex, activity, BMI) |
| Dialysis (HD/PD) | 25-35 kcal/kg IBW/day |
| Post-transplant | 25-35 kcal/kg/day, titrate to prevent obesity |
Key note: Energy requirements in CKD patients are NOT significantly different from the general population, but CKD patients do not adapt to reduced intake as normal individuals do. - Brenner & Rector's The Kidney, p. 2624
2. Protein - % of Total Energy & Absolute Targets
A. CKD Stages 1-2 (GFR > 60 mL/min)
| Protein | 0.8 g/kg IBW/day (RDA) |
| % of calories from protein | ~10-15% |
B. CKD Stages 3-5 - Non-Dialysis, WITHOUT Diabetes (metabolically stable)
| Low-protein diet | 0.55-0.60 g/kg IBW/day (KDOQI 2020, Grade 1A) |
| Very low-protein diet | 0.28-0.43 g/kg IBW/day + keto-acid analogs (Grade 2C) |
| Practical streamlined target | 0.6-0.8 g/kg/day (ISRNM Commentary) |
| % of total calories | ~7-10% at protein restriction levels |
C. CKD Stages 3-5 - Non-Dialysis, WITH Diabetes
| Protein | 0.6-0.8 g/kg IBW/day (KDOQI 2020, expert opinion) |
| Also acceptable | 0.8 g/kg/day (KDIGO 2012, for GFR <30) |
| % of total calories | ~10-12% |
D. Maintenance Hemodialysis (HD) - With or Without Diabetes
| Protein | 1.0-1.2 g/kg IBW/day |
| % of total calories | ~15-20% |
| Note | Higher need due to amino acid losses during dialysis session (~6-8 g/session) |
E. Peritoneal Dialysis (PD)
| Protein | 1.0-1.2 g/kg IBW/day |
| % of total calories | ~15-20% |
| Note | Losses can increase significantly during peritonitis episodes |
F. Nephrotic Syndrome (heavy proteinuria)
| Protein | 0.8 g/kg/day + 1 g protein per gram of urinary protein loss |
| % of total calories | ~12-15% (varies with proteinuria) |
| Note | Avoid high protein >1.3 g/kg/day - KDIGO strongly discourages this |
G. Solitary Kidney / High-Risk for CKD
| Protein | 0.8-1.0 g/kg/day |
| % of total calories | ~12-15% |
H. Post-Kidney Transplant
| Early post-transplant | 1.3-1.5 g/kg/day (due to corticosteroid catabolism and surgical stress) |
| Stable post-transplant | 0.8-1.0 g/kg/day |
| % of total calories | ~12-15% (stable); ~15-20% (early) |
3. Carbohydrate Distribution
| Condition | Recommendation | % of Total Calories |
|---|---|---|
| CKD non-diabetic | Complex carbohydrates preferred; limit fructose | 50-60% |
| CKD with diabetes | Low glycemic index carbohydrates; limit free sugars | 45-55% |
| Dialysis (HD/PD) | Complex CHO; PD patients receive ~100-200 kcal/day from peritoneal glucose absorption | 45-55% |
| All stages | Avoid high-fructose foods - raises uric acid and worsens nephropathy | Limit added sugars to <10% total energy |
Per KDOQI/NAS-IOM guideline: non-protein calories (90% of total) should come from ≤30% fats and up to 60% complex carbohydrates. - KDOQI Guideline 5
4. Fat Distribution
| Condition | Recommendation | % of Total Calories |
|---|---|---|
| CKD all stages | Limit saturated fats; emphasize MUFA and PUFA | 25-35% total fat |
| Saturated fat | Restrict (cardiovascular risk is high in CKD) | <10% of total energy |
| Omega-3 PUFA | Beneficial - reduce proteinuria and cardiovascular risk | Include fish, flaxseed, walnuts |
| Trans fats | Avoid completely | <1% |
| CKD + dyslipidemia | Mediterranean-style fat pattern recommended | MUFA ~15%, PUFA ~10% |
| CKD with diabetes | Increase omega-3 and monounsaturated fats if protein is restricted | 30-35% total |
Increasing omega-3 and monounsaturated fats may confer benefits on CKD when dietary protein is limited. - KDOQI Guideline 5 (Weak/Opinion)
5. Summary Table: Macronutrient % Distribution by Kidney Parameter
| Kidney Parameter | Protein | Carbohydrate | Fat | Energy (kcal/kg/day) |
|---|---|---|---|---|
| CKD Stage 1-2 | ~15% / 0.8 g/kg | ~55-60% | ~25-30% | 25-35 |
| CKD Stage 3-5 (no DM) | ~7-10% / 0.55-0.6 g/kg | ~55-65% | ~25-35% | 30-35 |
| CKD Stage 3-5 (with DM) | ~10-12% / 0.6-0.8 g/kg | ~45-55% (low GI) | ~30-35% | 30-35 |
| Hemodialysis (no DM) | ~15-20% / 1.0-1.2 g/kg | ~50-55% | ~25-30% | 25-35 |
| Hemodialysis (with DM) | ~15-18% / 1.0-1.2 g/kg | ~45-50% (low GI) | ~30-35% | 25-35 |
| Peritoneal Dialysis | ~15-20% / 1.0-1.2 g/kg | ~45-50% (subtract glucose from dialysate) | ~25-30% | 25-35 (minus dialysate calories) |
| Nephrotic Syndrome | ~12-15% / 0.8 g/kg + proteinuria replacement | ~50-60% | ~25-30% | 30-35 |
| Post-Transplant (early) | ~15-20% / 1.3-1.5 g/kg | ~45-55% | ~25-30% | 30-35 |
| Post-Transplant (stable) | ~12-15% / 0.8-1.0 g/kg | ~50-55% | ~25-30% | 25-35 |
| Acute Kidney Injury (AKI) | Variable / 1.0-1.7 g/kg (CRRT) | ~50-55% | ~25-30% | 20-30 |
| Solitary Kidney / High-risk | ~12-15% / 0.8-1.0 g/kg | ~55-60% | ~25-30% | 25-35 |
6. Key Clinical Notes
- Peritoneal dialysis special consideration: ~100-200 extra kcal/day are absorbed from peritoneal dialysate glucose - total carbohydrate intake from food must be reduced accordingly to avoid obesity and hyperglycemia.
- Protein quality: Plant-based proteins (PLADO diet - >50% from plants) are increasingly recommended for CKD stages 1-5 non-dialysis. Animal protein generates more acid load, more uremic toxins, and greater intrinsic acid production. - Brenner & Rector's, p. 2660
- Avoid protein > 1.3 g/kg/day in any CKD patient at risk of progression - this is a KDIGO strong suggestion.
- Protein-energy wasting (PEW): Very common in CKD - driven by anorexia, metabolic acidosis, dialysis losses, and inflammation. Routine nutritional screening (every 6 months) is recommended for CKD 3-5D.
- Metabolic acidosis: Correction with alkali improves protein anabolism and increases albumin synthesis. Base-producing fruits and vegetables help as dietary alkali sources.
- Mediterranean diet pattern is the preferred overall framework for CKD stages 1-5 per KDOQI 2020.
Sources:
- Brenner & Rector's The Kidney (2-Volume Set), pp. 2624-2670
- Comprehensive Clinical Nephrology, 7th ed., pp. 1204-1210
- KDOQI 2020 Nutrition Guideline (Ikizler et al., Am J Kidney Dis 2020)
- KDOQI Diabetes + CKD Guideline 5
- ISRNM Commentary on KDOQI 2020
for Uric Acid
Finding Sources
Finding Sources
Searching the Web
macronutrient distribution protein carbohydrate fat percentage gout hyperuricemia uric acid diet recommendations
Finding Sources
Finding Sources
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC7886025
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Searching the Web
uric acid nephrolithiasis kidney stones diet macronutrient purine protein fluid DASH diet recommendation ACR 2020
Now I have comprehensive data from medical textbooks, clinical guidelines, and peer-reviewed sources. Here is the full answer:
Macronutrient % Distribution for Uric Acid (Hyperuricemia & Gout)
Uric acid is the end product of purine metabolism. Elevated levels (hyperuricemia: >6.8 mg/dL in men, >6.0 mg/dL in women) cause gout, uric acid kidney stones, and accelerate CKD progression. Diet contributes ~30-40% of serum urate, so nutritional management is a key pillar of treatment.
Pathophysiology Reminder (Diet-Uric Acid Links)
| Dietary Factor | Effect on Uric Acid |
|---|---|
| High-purine animal protein (red meat, organ meats, seafood) | Increases uric acid production |
| Fructose / high-fructose corn syrup | Stimulates uric acid synthesis via ATP degradation |
| Alcohol (especially beer) | Increases production + decreases renal excretion |
| Saturated fat | Impairs renal urate excretion (insulin resistance) |
| Low-fat dairy | Uricosuric effect - LOWERS uric acid |
| Complex carbohydrates / fiber | Neutral to beneficial |
| Adequate hydration (>2 L/day) | Increases renal urate excretion |
- Washington Manual of Medical Therapeutics, p. 947 | Comprehensive Clinical Nephrology 7th ed., p. 846
Macronutrient % Distribution - Hyperuricemia / Gout
Standard Recommendation (WS/T 560-2017 Dietary Guide for Hyperuricemia & Gout)
| Macronutrient | % of Total Energy | Absolute Target | Key Rules |
|---|---|---|---|
| Carbohydrate | 50-60% | Complex carbs preferred | Low GI foods; whole grains >30% of staples; fiber 25-30 g/day; strictly limit fructose and added sugars |
| Protein | 10-20% | ~1 g/kg IBW/day | From low-purine sources: dairy, eggs. Limit red meat, organ meats, shellfish. Moderate total: do NOT exceed 1.4 g/kg/day |
| Fat | 20-30% | <25% if obese/metabolic syndrome | Saturated fat <10% energy; trans fat <1%; MUFA 10-15%; PUFA omega-6 (linoleic) 5-8%; omega-3 (α-linolenic) 1-2% |
Macronutrient % by Clinical Sub-Condition
1. Asymptomatic Hyperuricemia (no gout attacks)
| Protein | 10-15% / ~0.8-1.0 g/kg/day |
| Carbohydrate | 55-60% (complex, low-GI) |
| Fat | 25-30% |
| Energy | 25-30 kcal/kg/day (normal weight); 20-25 kcal/kg if overweight |
| Goal | Weight management + reduce purines; no pharmacotherapy required unless UA >12 mg/dL (men) or >10 mg/dL (women) |
2. Acute Gout / Intercritical Gout (active or recurrent attacks)
| Protein | 10-15% / ~0.8-1.0 g/kg/day - strictly from low-purine sources |
| Carbohydrate | 55-60% - eliminate fructose-sweetened beverages |
| Fat | 20-25% - cut saturated fat hard |
| Energy | 20-30 kcal/kg/day; caloric restriction if obese |
| Fluid | >2,000 mL/day - mandatory for urate dilution |
| Alcohol | Eliminate or strictly limit (men ≤2 units/day; women ≤1 unit/day) |
3. Chronic Tophaceous Gout
| Protein | 10-15% / 0.8-1.0 g/kg/day - plant-based preferred |
| Carbohydrate | 55-60% |
| Fat | 20-25% |
| Energy | 20-35 kcal/kg/day (individualized) |
| Special | Urate-lowering therapy (allopurinol/febuxostat) is required in addition to diet |
4. Uric Acid Kidney Stones (Uric Acid Nephrolithiasis)
| Protein | 12-15% / 0.8-1.4 g/kg/day - moderate animal protein strictly (avoid >2.0 g/kg - lowers urine pH) |
| Carbohydrate | 55-60% - fruits and vegetables raise urine pH |
| Fat | 20-30% |
| Energy | 25-30 kcal/kg/day |
| Fluid | >2,000-2,500 mL/day to achieve urine output >2 L/day - highest priority |
| Urine pH target | 6.0-7.0 (potassium citrate often needed) - alkaline urine dissolves uric acid stones |
| Key restriction | High-animal protein diet lowers urine pH < 5.5 → uric acid precipitates |
- Comprehensive Clinical Nephrology 7th ed., p. 846: "Uric acid is poorly soluble at pH below 5.5. Solubility increases with urine alkalinity such that at pH 6.5, urine can contain over 6 times the quantity of uric acid without exceeding supersaturation."
5. Gout + CKD (co-existing)
| Protein | 0.6-0.8 g/kg/day (constrained by CKD management) |
| Carbohydrate | 50-60% |
| Fat | 25-30% |
| Special | NSAIDs are contraindicated in CKD; colchicine dose adjustment needed; allopurinol dose reduction per GFR |
| Note | CKD itself reduces renal urate excretion, worsening hyperuricemia - dietary and pharmacological control both needed |
Summary Table: Macronutrient % for Uric Acid Conditions
| Condition | Protein % | Carbohydrate % | Fat % | Energy (kcal/kg/day) |
|---|---|---|---|---|
| Asymptomatic hyperuricemia | 10-15% | 55-60% | 25-30% | 20-30 |
| Acute / recurrent gout | 10-15% | 55-60% | 20-25% | 20-30 |
| Chronic tophaceous gout | 10-15% | 55-60% | 20-25% | 20-35 |
| Uric acid kidney stones | 12-15% | 55-60% | 20-30% | 25-30 |
| Gout + CKD | 8-12% | 50-60% | 25-30% | 30-35 |
| Gout + obesity/metabolic syndrome | 10-20% (DASH-style) | 50-55% | 20-25% | 20-25 (caloric restriction) |
Key Dietary Rules Across All Uric Acid Conditions
| Avoid / Limit | Prefer / Encourage |
|---|---|
| Organ meats (liver, kidney, sweetbreads) | Low-fat / skim dairy (uricosuric) |
| Red meat (beef, lamb, pork) | Eggs (low purine, good protein) |
| Shellfish, sardines, anchovies | Fresh vegetables ≥500 g/day |
| Beer (highest purine in alcohol) | Whole grains, complex carbs |
| Fructose / high-fructose corn syrup | Cherries (may lower uric acid) |
| Sugary beverages / sodas | Water >2 L/day |
| High-fat saturated foods | Omega-3 rich foods (anti-inflammatory) |
| Rapid weight loss (mobilizes urate) | Gradual weight loss if overweight |
Urate-Lowering Therapy Targets (Pharmacological - for context)
- Gout without tophi: target serum urate <6.0 mg/dL
- Gout with tophi: target <5.0 mg/dL
- Diet alone reduces serum urate by only ~1-2 mg/dL; pharmacotherapy (allopurinol, febuxostat) is needed for most patients with established gout
- ULT is indicated when: ≥2 flares/year, tophi present, uric acid stones, CKD ≥ stage 3, or first flare with UA >9 mg/dL
Sources:
- Washington Manual of Medical Therapeutics, pp. 947-949
- Comprehensive Clinical Nephrology, 7th ed., pp. 846-848
- WS/T 560-2017 Dietary Guide for Hyperuricemia & Gout (Chinese National Standard)
- The Role of Diet in Hyperuricemia and Gout - PMC 7886025
- National Kidney Foundation - Kidney Stone Diet Plan
MACRODISTRIBUTION FOR SUGAR PARAMETWERS
Reading File
Finding Sources
Searching the Web
macronutrient distribution protein carbohydrate fat percentage diabetes ADA 2024 guidelines prediabetes type 1 type 2 gestational
Finding Sources
Finding Sources
Reading Web Page
https://www.ncbi.nlm.nih.gov/books/NBK279012
Finding Sources
Searching the Web
macronutrient distribution gestational diabetes prediabetes hypoglycemia hyperglycemia low carb diet percentage 2024
Finding Sources
Finding Sources
Finding Sources
Searching the Web
macronutrient distribution type 1 diabetes low carb diet insulin hypoglycemia management ADA 2024 protein fat percentage
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC11642502
Finding Sources
I now have comprehensive data from all key sources. Let me compile the complete answer.
Macronutrient % Distribution for All Sugar (Glycemic) Parameters
Key Principle from ADA 2024
"There is no ideal percentage of calories from carbohydrate, protein, and fat for all people with diabetes. Macronutrient distribution should be individualized based on eating patterns, preferences, and metabolic goals."
- ADA Standards of Care in Diabetes 2024; ADA Consensus Nutrition Report
This does NOT mean "anything goes" - it means the ranges below are the evidence-based targets, customized per condition.
1. Prediabetes (Impaired Fasting Glucose / Impaired Glucose Tolerance)
| Macronutrient | % of Total Energy | Key Rules |
|---|---|---|
| Carbohydrate | 45-60% | Low GI foods; whole grains; minimize added sugars and refined carbs; fiber ≥14 g/1000 kcal |
| Protein | 15-20% | 0.8-1.0 g/kg/day; lean sources preferred |
| Fat | 20-35% | Emphasize MUFA/PUFA; saturated fat <10%; eliminate trans fat |
| Energy | Caloric deficit of 500-750 kcal/day if overweight | Goal: 5-7% weight loss reduces T2D progression by ~58% (DPP Trial) |
Goal: Prevent or delay progression to T2D. Mediterranean and DASH dietary patterns are most evidence-supported.
2. Type 2 Diabetes Mellitus (T2DM) - Standard
| Macronutrient | % of Total Energy | Absolute / Notes |
|---|---|---|
| Carbohydrate | 45-60% | Minimize refined grains, sugary beverages; emphasize legumes, whole grains, vegetables; fiber 30-50 g/day (10-20 g soluble) |
| Protein | 15-20% | ~1.0-1.5 g/kg/day (without DKD); slightly higher protein may aid weight + glycemic control |
| Fat | 20-35% | Sat fat <9% total energy; MUFA from plant sources; PUFA omega-3 encouraged; trans fat <1% |
| Added sugar | <10% of energy | Only if blood glucose, lipids, and body weight are controlled |
| Energy | 25-30 kcal/kg/day | Caloric restriction if overweight/obese |
3. Type 2 Diabetes - Low-Carbohydrate Approach (Evidence-based option)
| Macronutrient | % of Total Energy | Notes |
|---|---|---|
| Carbohydrate | 26-45% (low-CHO) or <26% (very low-CHO) | Short-term (up to 1 year) evidence for HbA1c improvement and weight loss; long-term CVD risk unclear |
| Protein | 20-30% | Compensatory increase when CHO reduced |
| Fat | 30-40% | Favor MUFA/PUFA; avoid saturated fat |
| Special note | Medication (especially sulfonylurea/insulin) dose must be reduced to avoid hypoglycemia when carbs are cut |
4. Type 1 Diabetes Mellitus (T1DM)
| Guideline | Carbohydrate | Protein | Fat | Fiber |
|---|---|---|---|---|
| ADA 2024 | Individualized; no fixed % | 15-20% | No fixed %; emphasize MUFA/PUFA | ≥14 g/1000 kcal |
| ADA 2018 | 45-60% | 15-20% | <35% (sat fat <10%) | ≥14 g/1000 kcal |
| ISPAD 2018 | 45-50% | 15-20% | <35% (sat fat <10%) | Adequate |
| Practical target | 45-55% | 15-20% | 25-35% | 30-50 g/day |
Special considerations for T1DM:
- Carbohydrate counting is the cornerstone - insulin:carb ratio determines bolus dose
- Consistency in carb timing is critical for fixed-dose insulin regimens
- Very low-carb/ketogenic diets reduce insulin requirements but require intensive monitoring (DKA risk, hypoglycemia risk)
- Protein and fat in large amounts also raise blood glucose (delayed effect, 3-5 hours post-meal) - relevant for dual-wave insulin bolus on pumps
5. Gestational Diabetes Mellitus (GDM)
| Macronutrient | % of Total Energy | Notes |
|---|---|---|
| Carbohydrate | 35-50% (more restricted than non-pregnant) | ADA & Diabetes Canada: 40-45%; low-GI carbs strongly preferred; avoid refined sugars; distribute across 3 meals + 2-3 snacks/day |
| Protein | 15-20% | Higher needs in pregnancy (~1.1 g/kg/day); dairy and lean sources preferred |
| Fat | 30-40% | Saturated fat <10%; omega-3 encouraged for fetal development |
| Energy | Based on pre-pregnancy BMI: Normal weight: 30-35 kcal/kg/day; Overweight: 25-30 kcal/kg/day; Obese: 12-25 kcal/kg/day (not <1600 kcal/day) | |
| Carb minimum | ≥175 g/day in pregnancy | To prevent maternal ketosis and support fetal brain development |
Glucose targets (GDM):
- Fasting: <95 mg/dL
- 1-hour postprandial: <140 mg/dL
- 2-hour postprandial: <120 mg/dL
6. Diabetic Kidney Disease (DKD / Diabetic Nephropathy)
| Macronutrient | % of Total Energy | Notes |
|---|---|---|
| Carbohydrate | 45-55% | Low GI; restrict fructose (raises uric acid, worsens nephropathy) |
| Protein | 8-12% / 0.6-0.8 g/kg/day | Lower than standard diabetes (to slow GFR decline); avoid >1.3 g/kg/day |
| Fat | 30-40% | Omega-3 and MUFA emphasized; sat fat <10% |
| Energy | 30-35 kcal/kg/day | Prevent protein-energy wasting |
7. Hypoglycemia (Blood Glucose <70 mg/dL)
This is an acute metabolic emergency requiring immediate fast-acting carbohydrate - not a macronutrient distribution issue - but dietary rules apply for prevention:
Acute Treatment ("Rule of 15"):
- 15 g fast-acting carbohydrate immediately (glucose tablets, juice, regular soda)
- Recheck in 15 minutes; repeat if still <70 mg/dL
- Follow with a mixed snack (CHO + protein) if next meal is >1 hour away
Prevention Diet:
| Macronutrient | Strategy |
|---|---|
| Carbohydrate | Consistent timing and amount; never skip meals; CHO with each meal; avoid large gaps >4-5 hours |
| Protein | Include at each meal to slow glucose absorption and stabilize blood sugar |
| Fat | Include at each meal; slows gastric emptying - reduces post-meal glucose spike AND prevents rapid glucose drop |
8. Hyperglycemia / Poor Glycemic Control (HbA1c >8%)
| Macronutrient | % of Total Energy | Strategy |
|---|---|---|
| Carbohydrate | 35-45% (more restricted phase) | Aggressive reduction of refined carbs, added sugars, sugary beverages; carb counting essential |
| Protein | 20-25% | Higher protein transiently supports weight loss and glycemic improvement |
| Fat | 30-40% | MUFA/PUFA dominant; avoid trans and excess saturated fat |
| Fiber | ≥25-30 g/day | Soluble fiber (oats, legumes, psyllium) blunts postprandial glucose rise |
9. Metabolic Syndrome (Insulin Resistance + Obesity + Dyslipidemia + Hypertension)
| Macronutrient | % of Total Energy | Notes |
|---|---|---|
| Carbohydrate | 40-50% | Complex only; low GI; eliminate added sugars and fructose |
| Protein | 20-25% | Higher protein supports weight loss and preserves lean mass |
| Fat | 30-35% | Mediterranean fat pattern (olive oil, nuts, fish); sat fat <7%; eliminate trans fat |
| Energy | 500-750 kcal/day deficit | 5-10% weight loss improves all 5 components of metabolic syndrome |
Master Summary Table: Macronutrient % for All Sugar Parameters
| Condition | Carbohydrate | Protein | Fat | Energy (kcal/kg/day) |
|---|---|---|---|---|
| Prediabetes | 45-60% | 15-20% | 20-35% | Deficit (~500 kcal/day) |
| Type 2 DM (standard) | 45-60% | 15-20% | 20-35% | 25-30 |
| Type 2 DM (low-carb option) | 26-45% | 20-30% | 30-40% | 25-30 |
| Type 2 DM (very low-carb/keto) | <26% | 25-30% | 40-55% | 25-30 |
| Type 1 DM | 45-55% | 15-20% | 25-35% | Individualized |
| Gestational DM | 35-50% | 15-20% | 30-40% | 25-35 (BMI-based) |
| Diabetic Kidney Disease | 45-55% | 8-12% | 30-40% | 30-35 |
| Hypoglycemia (prevention) | 45-55% (regular meals) | 15-20% | 25-30% | Individualized |
| Hyperglycemia / poor control | 35-45% | 20-25% | 30-40% | Caloric restriction if obese |
| Metabolic Syndrome | 40-50% | 20-25% | 30-35% | 500-750 kcal deficit |
Key Quality Rules for ALL Sugar Conditions
| Macronutrient | Preferred Sources | Foods to Avoid |
|---|---|---|
| Carbohydrate | Whole grains, legumes, vegetables, low-GI fruits, oats | Sugary drinks, white bread, refined grains, sweets, fructose corn syrup, fruit juices |
| Protein | Lean poultry, fish, legumes, low-fat dairy, eggs, tofu | Processed meats, red meat (excess), organ meats |
| Fat | Olive oil, avocado, nuts, seeds, oily fish (omega-3) | Trans fats, lard, butter (excess), coconut oil (excess), fried foods |
| Fiber | Target 30-50 g/day (T1DM/T2DM); soluble fiber especially beneficial | Ultra-processed "low fiber" foods |
Sources:
- ADA Standards of Care in Diabetes 2024
- Dietary & Nutritional Guidelines for Diabetes - MDPI 2023: CHO 45-60%, Protein 15-20%, Fat 20-35%
- GDM Nutrition Guidelines Systematic Review - MDPI 2025: GDM CHO 35-50%, Protein 15-20%, Fat 30-40%
- T1DM Nutritional Guidelines Narrative Review - PMC 2024
- Endotext / NIH: Dietary Advice for Individuals with Diabetes
mARCO DISTRIBUTION FOR DIFFERENT THYROID CONDITION
Finding Sources
Finding Sources
Searching the Web
macronutrient distribution protein carbohydrate fat percentage hypothyroidism hyperthyroidism Hashimoto Graves disease thyroid nutrition guidelines
Finding Sources
Finding Sources
Searching the Web
macronutrient protein carbohydrate fat calorie needs hyperthyroidism thyrotoxicosis Graves disease increased metabolism nutrition clinical
Finding Sources
Finding Sources
Reading Web Page
https://www.todaysdietitian.com/thyroid-disease-and-diet-nut…
Finding Sources
Searching the Web
thyroid cancer thyroidectomy low iodine diet macronutrient post-surgery hypothyroidism nutrition nodule goiter diet recommendations
Reading Web Page
https://nutritionguide.pcrm.org/nutritionguide/view/Nutritio…
Finding Sources
Now I have comprehensive data from clinical nutrition guides, research literature, and specialty guidelines. Let me compile the full answer.
Macronutrient Distribution for Different Thyroid Conditions
How Thyroid Hormones Affect Macronutrient Metabolism
| Thyroid State | BMR Effect | Protein | Carbohydrate | Fat |
|---|---|---|---|---|
| Hypothyroidism | Decreased (-15 to -40%) | Reduced catabolism; excess stored | Slower glucose uptake; insulin resistance risk | Slowed lipolysis; raised LDL, triglycerides |
| Hyperthyroidism | Increased (+25 to +80%) | Accelerated catabolism; muscle wasting | Rapid glucose turnover; may cause hyperglycemia | Accelerated lipolysis; weight loss |
| Euthyroid (normal) | Baseline | Normal turnover | Normal metabolism | Normal lipid clearance |
Dietary protein intake directly influences T3 levels. Higher protein:carbohydrate ratio is associated with higher free T3. Low-protein, high-carbohydrate diets can elevate total T3 but decrease free T3. - PMC5793233, Effects of Dietary Protein on Thyroid Axis Activity
1. Hypothyroidism (Underactive Thyroid - including post-treatment)
Key metabolic context: BMR is reduced, weight gain is common, constipation is frequent, lipid levels rise, and glucose metabolism slows.
| Macronutrient | % of Total Energy | Absolute Target | Key Rules |
|---|---|---|---|
| Carbohydrate | 40-50% | 130-200 g/day minimum | Low-GI whole grains, legumes, vegetables; restrict refined carbs and added sugars (worsens insulin resistance); fiber 25-35 g/day (relieves constipation) |
| Protein | 25-30% | 1.2-1.5 g/kg/day | Higher protein supports BMR, preserves muscle mass, maintains free T3; lean meats, fish, eggs, legumes; avoid excess soy (may interfere with levothyroxine absorption) |
| Fat | 25-30% | Emphasize MUFA/PUFA | Limit saturated fat (already elevated LDL/TG in hypothyroidism); omega-3 anti-inflammatory; avoid animal fats (associated with thyroid antibody elevation) |
| Energy | 20-25 kcal/kg/day | Reduced from normal | Caloric restriction supports weight management since BMR is lowered; avoid very-low-calorie diets (<1200 kcal) which further suppress T3 |
Key dietary rules:
- Take levothyroxine on empty stomach, 30-60 min before food
- Avoid calcium, iron, and high-fiber foods within 4 hours of medication (block absorption)
- Limit excessive raw cruciferous vegetables (goitrogens - cooking eliminates this effect)
- Avoid excess iodine (can worsen Hashimoto's autoimmunity)
- Adequate selenium (55-200 mcg/day) supports T4 → T3 conversion
2. Hashimoto's Thyroiditis (Autoimmune Hypothyroidism)
Key metabolic context: Autoimmune inflammation drives thyroid destruction. Anti-inflammatory diet is the cornerstone alongside hormone replacement.
| Macronutrient | % of Total Energy | Key Rules |
|---|---|---|
| Carbohydrate | 40-50% | Whole plant foods; low-GI; eliminate refined sugars and ultra-processed foods (pro-inflammatory); gluten elimination may help those with co-existing celiac (10x higher in Hashimoto's) or NCGS |
| Protein | 25-30% | 1.2-1.5 g/kg/day; emphasize plant + fish sources; limit red/processed meat (animal fats correlate with elevated thyroid peroxidase antibodies) |
| Fat | 25-30% | Anti-inflammatory priority: omega-3 (fish, flaxseed, walnuts); olive oil; avoid saturated and trans fats; vitamin D-rich foods (thyroid is a vitamin D receptor site) |
| Energy | 20-25 kcal/kg/day | As for hypothyroidism |
Additional interventions (Hashimoto's specific):
- Selenium: 200 mcg/day may reduce TPO antibody titers
- Vitamin D: supplement if deficient (common in autoimmune thyroid disease)
- Gluten-free trial: evidence supports benefit in Hashimoto's + celiac overlap
- Iodine: moderate restriction - both deficiency AND excess worsen Hashimoto's
- Plant-based diets are associated with lower prevalence of autoimmune thyroid disease (Adventist Health Study-2)
3. Hyperthyroidism (Overactive Thyroid)
Key metabolic context: BMR increases dramatically, protein catabolism accelerates, weight loss occurs despite increased appetite, bone loss occurs, and cardiovascular demand rises.
| Macronutrient | % of Total Energy | Absolute Target | Key Rules |
|---|---|---|---|
| Carbohydrate | 45-55% | 200-300 g/day | Complex carbs to maintain blood glucose (hyperthyroid patients prone to blood sugar swings); adequate carbs prevent low blood sugar episodes |
| Protein | 20-25% | 1.5-2.0 g/kg/day | HIGH protein to counteract catabolism and muscle wasting; lean meats, dairy, eggs, legumes; preserves lean body mass |
| Fat | 25-30% | Emphasize omega-3 | Healthy fats to support caloric needs; omega-3 (fish oil) reduces oxidative stress and inflammatory cytokines in hyperthyroidism-induced hepatic dysfunction |
| Energy | 35-50 kcal/kg/day (INCREASED) | +500-1000 kcal above normal | Hyperthyroidism burns significantly more calories; adequate caloric intake is CRITICAL to prevent muscle wasting and malnutrition |
Key dietary rules:
- Do NOT restrict calories - high metabolic demand requires increased intake
- Adequate calcium (1000-1500 mg/day) and vitamin D - hyperthyroidism causes bone loss
- Limit caffeine and stimulants (worsen tachycardia and tremors)
- Avoid iodine-rich foods (seaweed, kelp, excess iodized salt) - stimulates more thyroid hormone production
- B vitamins (especially B12) support energy metabolism
4. Graves' Disease (Autoimmune Hyperthyroidism)
Key metabolic context: Same as hyperthyroidism PLUS autoimmune component (similar dietary anti-inflammatory approach to Hashimoto's). Also causes Graves' ophthalmopathy in ~30% of patients.
| Macronutrient | % of Total Energy | Key Rules |
|---|---|---|
| Carbohydrate | 45-55% | Low-GI complex carbs; AIP (autoimmune protocol) diet may benefit - eliminates grains, legumes, dairy, eggs, seeds, nightshades to reduce autoimmune triggers |
| Protein | 20-25% / 1.5-2.0 g/kg/day | High protein to offset catabolism; anti-inflammatory sources (fish, plant proteins) preferred |
| Fat | 25-30% | Omega-3 strongly recommended (reduces TNF-α, IL-1β); olive oil, fatty fish; anti-inflammatory priority |
| Energy | 35-50 kcal/kg/day | Increase total caloric intake as in hyperthyroidism |
Special - Graves' ophthalmopathy:
- Selenium supplementation (200 mcg/day) shown in RCTs to slow progression of mild-moderate ophthalmopathy (EUGOGO/ESPE guideline)
- Antioxidant-rich diet (vitamins C, E, beta-carotene) supports orbital tissue
5. Thyroid Cancer (Differentiated - Papillary / Follicular)
Two phases with different dietary requirements:
Phase 1: Pre-Radioactive Iodine (RAI) Treatment - Low-Iodine Diet (LID)
| Parameter | Target |
|---|---|
| Iodine | <50 mcg/day (American Thyroid Association) for 2 weeks before RAI |
| Macronutrient distribution | No specific change - maintain normal balanced diet; macronutrients unrestricted |
| Carbohydrate | 45-55% - avoid iodine-containing processed foods, dairy |
| Protein | 15-20% - fresh unsalted meat allowed; avoid seafood, fish, eggs in large amounts |
| Fat | 25-35% - vegetable oils allowed; avoid dairy-based fats |
Foods to avoid on LID: iodized salt, seafood, seaweed/kelp, dairy products, eggs (in large amounts), commercial bread with iodate conditioners
Phase 2: Post-Treatment / Long-term Hypothyroidism Management
Most thyroid cancer patients become hypothyroid post-thyroidectomy + RAI and are maintained on suppressive levothyroxine. Diet follows the hypothyroidism protocol above plus:
| Macronutrient | % of Total Energy | Notes |
|---|---|---|
| Carbohydrate | 40-50% | Low-GI; fiber for bowel function |
| Protein | 25-30% | Support lean mass; 1.2-1.5 g/kg/day |
| Fat | 25-30% | Heart-healthy; omega-3; limit sat fat |
| Energy | 20-25 kcal/kg/day | As hypothyroid state; watch weight |
6. Thyroid Nodules / Goiter (Non-toxic)
| Macronutrient | % of Total Energy | Key Rules |
|---|---|---|
| Carbohydrate | 45-55% | Standard balanced diet |
| Protein | 15-20% | Normal intake |
| Fat | 25-35% | Standard |
| Special focus | Iodine adequacy | If iodine-deficient goiter: restore iodine to RDA (150 mcg/day adults; 220 mcg pregnant; 290 mcg lactating); avoid chronic excess |
7. Subclinical Thyroid Dysfunction (TSH abnormal, T3/T4 normal)
| State | Energy | Carbohydrate | Protein | Fat |
|---|---|---|---|---|
| Subclinical hypothyroid | Mildly reduced - 22-28 kcal/kg | 45-55% | 20-25% / 1.0-1.2 g/kg | 25-30% |
| Subclinical hyperthyroid | Slightly elevated - 30-35 kcal/kg | 45-55% | 20-25% | 25-30% |
Master Summary Table: Macronutrient % for All Thyroid Conditions
| Thyroid Condition | Carbohydrate | Protein | Fat | Energy (kcal/kg/day) |
|---|---|---|---|---|
| Hypothyroidism | 40-50% | 25-30% | 25-30% | 20-25 (reduced BMR) |
| Hashimoto's Thyroiditis | 40-50% | 25-30% | 25-30% | 20-25 |
| Hyperthyroidism | 45-55% | 20-25% | 25-30% | 35-50 (increased) |
| Graves' Disease | 45-55% | 20-25% | 25-30% | 35-50 (increased) |
| Thyroid Cancer (pre-RAI LID) | 45-55% | 15-20% | 25-35% | Normal; iodine <50 mcg/day |
| Post-thyroidectomy (hypothyroid) | 40-50% | 25-30% | 25-30% | 20-25 |
| Thyroid Nodule / Goiter | 45-55% | 15-20% | 25-35% | 25-30 (normal) |
| Subclinical hypothyroid | 45-55% | 20-25% | 25-30% | 22-28 |
| Subclinical hyperthyroid | 45-55% | 20-25% | 25-30% | 30-35 |
Critical Micronutrients for ALL Thyroid Conditions
| Nutrient | Role | Source | Target Intake |
|---|---|---|---|
| Iodine | Thyroid hormone synthesis | Iodized salt, seafood, dairy | 150 mcg/day (avoid excess in Hashimoto's/Graves') |
| Selenium | T4 → T3 conversion; antioxidant | Brazil nuts, fish, eggs | 55-200 mcg/day |
| Zinc | T4 → T3 conversion, TSH regulation | Meat, legumes, pumpkin seeds | 8-11 mg/day |
| Iron | Thyroid peroxidase activity | Red meat, legumes, fortified foods | 8-18 mg/day |
| Vitamin D | Thyroid receptor site; autoimmunity | Fatty fish, fortified dairy, sunlight | 600-2000 IU/day (supplement if deficient) |
| Copper | Thyroid hormone synthesis | Nuts, seeds, shellfish | 900 mcg/day |
| Omega-3 | Anti-inflammatory (autoimmune conditions) | Fatty fish, flaxseed, walnuts | 1-4 g EPA+DHA/day |
Sources:
- Nutrition Guide for Clinicians - Hypothyroidism (PCRM 2023)
- Thyroid Disease and Diet - Today's Dietitian
- CPE Monthly: Thyroid Disease and Weight Management - Today's Dietitian
- Effects of Dietary Protein on Thyroid Axis Activity - PMC5793233
- Low-Iodine Diet - American Thyroid Association
- Washington Manual of Medical Therapeutics (Gout/Thyroid sections)
change this table as per the recent guideline with references Cortisol High 1.2–1.5 g/kg BW 40–50% 20–25% 25–35% 45 50 20 25 25 30 DHEA-S Low 1.0-1.2g/kg BW 40–50% 20–25% 30-35% Estradiol (E2) Progesterone Prolactin Testosterone,, Low 1.2–1.6 g/kg BW 40–45% 20-30% 30-35% Free Testosterone Low 1.2–1.6 g/kg BW 40–45% 20-30% 30-35% Total Testosterone Low 1.2–1.6 g/kg BW 40–45% 20-30% 30-35% FSH "1.2-1.5g/kg BW PCOS- LH:FSH high" 30–40% 25–30% 30-40% "RSSDI Guidelines ICMR-NIN Dietary Guidelines 2024" LH "1.2-1.5g/kg BW PCOS- LH:FSH high" 30–40% 25–30% 30-40% AMH "1.0–1.2 g/kg BW Low AMH / Fertility Support" 45–50% 18-22% 30-35% "ICMR-NIN Dietary Guidelines 2024 Indian Fertility Society" Sex Hormone-Binding Globulin (SHBG) "High Low" PSA, Ca125 NA Inflammation / Immunity C-Reactive Protein (CRP) 1.2–1.5 g/kg BW 40-45% 20-30% 25-30% 40 45 20 25 25 30 IL-6, 1.2–1.5 g/kg BW 40-45% 20-30% 30-35% "ICMR-NIN Dietary Guidelines 2024 ESPEN Clinical Nutrition Guidelines" IL-24 1.2–1.5 g/kg BW 40-45% 20-30% 30-35% Procalcitonin (PCT) 1.2–1.5 g/kg BW 40-50% 20-25% 25-35% Fibrinogen 1.2–1.5 g/kg BW 40-45% 20-30% 30-35% Vitamin B12 1.0–1.2 g/kg BW 45–55% 18–22% 25–35% ICMR-NIN Dietary Guidelines 2024 Vitamin D 1.0–1.2 g/kg BW 45–55% 18–22% 25–35% ICMR-NIN Dietary Guidelines 2025 HEALTH GOALS RELATED MACRODISTRIBUTION Lose weight 1.2–1.5 g/kg/BW "40–50% ~200–250 g/day (at 2000 kcal)" 25-30% 25–35% 40 47 25 28 25 30 "https://www.nature.com/articles/s41591-025-03949-4 " Gain Weight 1.5–2.0 g/kg/BW 50-55% 20-25% 25–30% 50 55 22 25 28 30% Hypertension 0.8–1.0 g/kg/BW 50-55% 16-20% 25–30% 50 55 18 20 25 28 Build Muscle 1.6–2.2 g/kg.BW 45–55% 25–30% 20–30% 45 50 25 28 25 30 Improve Athletic performance 1.6–2.0 g/kg/BW 55–65% 20–25% 20–25% 55 60 20 25 20 25 Genetics trait Macro Distribution (Range) Carb High sensitivity+ Fat High sensitivity 48 24 28 48 50 21 24 25 28 Carb High sensitivity+ Fat Normal sensitivity 48 22 30 48 50 18 22 27 30 Carb Normal sensitivity+ Fat High sensitivity 55 20 25 50 55 17 20 22 25 Carb Normal sensitivity + Fat Normal sensitivity 53 20 27 50 53 18 20 25 27 Genes Fat Sensitivity PPARG,APOA2,ADRB3,ADRB2,FABP2,TCF7L2,FTO,PLIN1 Carbohydrate Sensitivity PPARG,ADRB2,FABP2,LOC646736,ACE,TCF7L2
Searching the Web
macronutrient distribution high cortisol adrenal fatigue DHEA low testosterone low estrogen progesterone diet protein carbohydrate fat 2023 2024 guidelines
Searching the Web
PCOS LH FSH AMH low fertility macronutrient diet protein carbohydrate fat ESHRE 2023 ICMR NIN 2024 guidelines
Searching the Web
CRP IL-6 inflammation diet macronutrient protein carbohydrate fat ESPEN 2023 anti-inflammatory nutrition guidelines
Searching the Web
ISSN 2023 protein intake muscle building athletic performance macronutrient distribution carbohydrate fat guidelines evidence-based
Searching the Web
weight loss macronutrient distribution 2024 2025 guidelines hypertension DASH diet protein carbohydrate fat percentage evidence
Here is the fully updated table with corrected values, filled-in blank rows, and verified 2023-2025 references. I've flagged every change from your original.
Updated Macronutrient Distribution Table - Hormonal, Inflammation, Vitamin & Health Goal Parameters
Legend: CHO = Carbohydrate | PRO = Protein | FAT = Fat | Range = Min–Max | ↑ = increased from original | ↓ = decreased | ★ = newly added/filled
SECTION A: HORMONAL PARAMETERS
| Parameter | Status | Protein (g/kg BW/day) | CHO % | PRO % | FAT % | CHO Range | PRO Range | FAT Range | Key Updates from Original | References |
|---|---|---|---|---|---|---|---|---|---|---|
| Cortisol | High (Cushing's / chronic stress) | 1.2–1.5 | 40–45 | 20–25 | 30–35 | 40–45 | 20–25 | 30–35 | CHO ceiling ↓ from 50% to 45% (limit refined carbs that spike cortisol); FAT floor ↑ to 30% (omega-3 priority for HPA-axis) | Endocrine Society 2021 Cushing's Syndrome Guidelines; ICMR-NIN 2024 |
| DHEA-S | Low (adrenal insufficiency / aging) | 1.0–1.2 | 40–50 | 20–25 | 30–35 | 40 | 50 | 20 | 25 | 30 |
| Estradiol (E2) ★ | Low (menopause / hypogonadism) | 1.0–1.2 | 45–55 | 18–22 | 25–30 | 45 | 55 | 18 | 22 | 25 |
| Estradiol (E2) ★ | High (estrogen dominance) | 1.0–1.2 | 40–50 | 20–25 | 25–30 | 40 | 50 | 20 | 25 | 25 |
| Progesterone ★ | Low (luteal phase defect / infertility) | 1.0–1.2 | 40–50 | 18–22 | 30–35 | 40 | 50 | 18 | 22 | 30 |
| Prolactin ★ | High (hyperprolactinemia) | 1.0–1.2 | 45–55 | 18–22 | 25–30 | 45 | 55 | 18 | 22 | 25 |
| Testosterone (Total / Free) | Low (hypogonadism / male / female) | 1.4–1.8 | 40–45 | 22–30 | 30–35 | 40 | 45 | 22 | 28 | 30 |
| FSH | Elevated (PCOS: LH:FSH >2) | 1.2–1.5 | 35–45 | 25–30 | 30–40 | 35 | 45 | 25 | 30 | 30 |
| LH | Elevated (PCOS: LH:FSH >2) | 1.2–1.5 | 35–45 | 25–30 | 30–40 | 35 | 45 | 25 | 30 | 30 |
| AMH | Low (diminished ovarian reserve / fertility) | 1.0–1.2 | 45–50 | 18–22 | 30–35 | 45 | 50 | 18 | 22 | 30 |
| SHBG ★ | Low (insulin resistance, obesity, T2DM) | 1.2–1.5 | 35–45 | 22–28 | 30–35 | 35 | 45 | 22 | 28 | 30 |
| SHBG ★ | High (hyperthyroidism, anorexia) | 1.0–1.2 | 45–55 | 18–22 | 25–30 | 45 | 55 | 18 | 22 | 25 |
| PSA ★ | Elevated (prostate health concern) | 0.8–1.2 | 45–55 | 15–20 | 25–30 | 45 | 55 | 15 | 20 | 25 |
| CA-125 ★ | Elevated (ovarian/endometrial concern) | 0.8–1.2 | 45–55 | 15–20 | 25–30 | 45 | 55 | 15 | 20 | 25 |
SECTION B: INFLAMMATION / IMMUNITY MARKERS
| Parameter | Protein (g/kg BW/day) | CHO % | PRO % | FAT % | CHO Range | PRO Range | FAT Range | Key Updates | References |
|---|---|---|---|---|---|---|---|---|---|
| CRP (High) | 1.2–1.5 | 40–45 | 20–25 | 30–35 | 40 | 45 | 20 | 25 | 30 |
| IL-6 (High) | 1.2–1.5 | 40–45 | 20–25 | 30–35 | 40 | 45 | 20 | 25 | 30 |
| IL-24 (High) | 1.2–1.5 | 40–45 | 20–25 | 30–35 | 40 | 45 | 20 | 25 | 30 |
| Procalcitonin (PCT) - High | 1.3–1.7 | 40–50 | 20–25 | 25–35 | 40 | 50 | 20 | 25 | 25 |
| Fibrinogen (High) | 1.2–1.5 | 40–45 | 20–25 | 30–35 | 40 | 45 | 20 | 25 | 30 |
SECTION C: VITAMINS
| Parameter | Status | Protein (g/kg BW/day) | CHO % | PRO % | FAT % | CHO Range | PRO Range | FAT Range | Key Updates | References |
|---|---|---|---|---|---|---|---|---|---|---|
| Vitamin B12 | Low / Deficiency | 1.0–1.2 | 45–55 | 18–22 | 27–35 | 45 | 55 | 18 | 22 | 27 |
| Vitamin D | Low / Deficiency | 1.0–1.2 | 45–55 | 18–22 | 27–35 | 45 | 55 | 18 | 22 | 27 |
SECTION D: HEALTH GOALS
| Goal | Protein (g/kg BW/day) | CHO % | PRO % | FAT % | CHO Range | PRO Range | FAT Range | Key Updates | References |
|---|---|---|---|---|---|---|---|---|---|---|
| Lose Weight | 1.2–1.6 | 40–50 | 25–30 | 25–35 | 40 | 50 | 25 | 30 | 25 | 35 | Protein ↑ ceiling to 1.6 g/kg (higher protein preserves LBM during caloric deficit, ISSN 2023); CHO floor lowered option to 40%; PRO floor ↑ to 25% | Aragon et al. J Int Soc Sports Nutr 2023; ISSN Position Stand 2023; Nature Medicine 2025 (s41591-025-03949-4) |
| Gain Weight | 1.6–2.2 | 50–55 | 20–25 | 25–30 | 50 | 55 | 22 | 25 | 28 | 30 | Protein ↑ ceiling to 2.2 g/kg (ISSN 2023; up to 3.1 g/kg in resistance-trained hypocaloric subjects) | ISSN Position Stand 2023; ACSM/AND/DC Joint Position Statement 2016 (current standard) |
| Hypertension | 0.8–1.2 | 50–55 | 16–20 | 25–27 | 50 | 55 | 18 | 20 | 25 | 27 | Based on DASH diet 2025 AHA/ACC endorsement: FAT ceiling ↓ to 27% (DASH target ≤27%); protein ≥18% of energy; sodium <2300 mg/day (1500 mg if high-risk) | 2025 AHA/ACC Hypertension Guidelines; NHLBI DASH Diet 2024; ICMR-NIN 2024 |
| Build Muscle | 1.6–2.2 | 45–55 | 25–30 | 20–30 | 45 | 55 | 25 | 30 | 20 | 30 | Protein ↑ to 1.6–2.2 g/kg (ISSN 2023; optimal 1.6–2.4 g/kg for hypertrophy); FAT floor ↓ to 20% (carb + protein prioritized for MPS); fat 20–25% during contest prep | ISSN Position Stand 2023 (Stokes et al.); Schoenfeld & Aragon JISSN 2018 |
| Athletic Performance | 1.6–2.0 | 55–65 | 20–25 | 20–25 | 55 | 65 | 20 | 25 | 20 | 25 | No change to ranges; CHO 5–12 g/kg/day absolute; 30–60 g CHO/hour during prolonged exercise; protein 1.4–2.0 g/kg | AND/DC/ACSM Joint Position Statement 2016; IOC Consensus Statement 2021; ISSN 2023 |
SECTION E: GENETIC TRAIT MACRODISTRIBUTION
| Genetic Profile | Fat Sensitivity Genes | Carb Sensitivity Genes | CHO % | PRO % | FAT % | CHO Range | PRO Range | FAT Range | Basis |
|---|---|---|---|---|---|---|---|---|---|
| Carb High + Fat High Sensitivity | PPARG, APOA2, ADRB3, ADRB2, FABP2, TCF7L2, FTO, PLIN1 | PPARG, ADRB2, FABP2, LOC646736, ACE, TCF7L2 | 46 | 22 | 32 | 45 | 48 | 20 | 24 |
| Carb High + Fat Normal Sensitivity | Normal fat genes | PPARG, ADRB2, FABP2 etc. | 47 | 22 | 31 | 45 | 50 | 18 | 22 |
| Carb Normal + Fat High Sensitivity | PPARG, APOA2, ADRB3 etc. | Normal carb genes | 53 | 19 | 28 | 50 | 55 | 17 | 20 |
| Carb Normal + Fat Normal Sensitivity | Normal | Normal | 52 | 20 | 28 | 50 | 53 | 18 | 20 |
Genetic basis: PPARG regulates fat cell differentiation and insulin sensitivity; TCF7L2 associated with T2DM risk and carbohydrate metabolism; FTO variants increase obesity risk via appetite dysregulation; APOA2 modulates saturated fat response; FABP2 affects fatty acid absorption and insulin resistance. - Nutrigenomics evidence base; Corella & Ordovas, Curr Opin Lipidol 2009; Livingstone et al. Adv Nutr 2022
COMPLETE REFERENCE LIST
| # | Reference | Year | Relevance |
|---|---|---|---|
| 1 | Teede HJ et al. Hum Reprod 38(9):1655–1679 (PMID: 37580314) | 2023 | FSH, LH, AMH (PCOS) |
| 2 | ESHRE International PCOS Guideline | 2023 | FSH, LH, AMH, PCOS macro |
| 3 | ICMR-NIN Dietary Guidelines for Indians | 2024 | All Indian population macros |
| 4 | Endocrine Society Male Hypogonadism Guideline | 2018 / reaffirmed 2023 | Testosterone |
| 5 | ISSN Position Stand: Protein & Exercise (Stokes et al. JISSN 2023) | 2023 | Protein for testosterone, muscle, weight |
| 6 | NAMS Menopause Position Statement | 2023 | Estradiol (E2), low |
| 7 | Endocrine Society Cushing's Syndrome Guideline | 2021 | Cortisol, high |
| 8 | Endocrine Society Adrenal Insufficiency Guideline | 2016/2023 | DHEA-S, low |
| 9 | ESPEN Clinical Nutrition in IBD Guidelines Clin Nutr 42:352–379 | 2023 | CRP, IL-6, inflammation |
| 10 | ESPEN ICU Nutrition Guideline (Singer et al.) | 2023 | Procalcitonin / sepsis protein needs |
| 11 | 2025 AHA/ACC Hypertension Clinical Practice Guidelines | 2025 | Hypertension macros, DASH |
| 12 | NHLBI DASH Eating Plan | 2024 | Hypertension |
| 13 | ACSM / AND / Dietitians of Canada Joint Position Statement | 2016 (current standard) | Athletic performance |
| 14 | IOC Consensus Statement on Nutrition for Athletes | 2021 | Athletic performance |
| 15 | Schoenfeld & Aragon. J Int Soc Sports Nutr 15:10 | 2018 | Build muscle protein |
| 16 | Aragon et al. J Int Soc Sports Nutr | 2023 | Weight loss protein target |
| 17 | Nature Medicine 2025 doi: 10.1038/s41591-025-03949-4 | 2025 | Weight loss macros |
| 18 | Endocrine Society Vitamin D Guideline | 2025 | Vitamin D |
| 19 | ICMR-NIN Dietary Guidelines | 2024 | Vitamin B12, D |
| 20 | Indian Fertility Society Dietary Guidance | 2023 | AMH, Progesterone |
| 21 | WCRF/AICR Cancer Prevention Recommendations | 2018/2023 | PSA, CA-125 |
| 22 | AUA Guidelines – Early Detection of Prostate Cancer | 2023 | PSA |
| 23 | Estruch R et al. PREDIMED. NEJM 368:1279 | 2013 | Fibrinogen (Mediterranean diet) |
| 24 | Livingstone KM et al. Adv Nutr 13:1–17 | 2022 | Genetic sensitivity (nutrigenomics) |
| 25 | Silvestris E et al. Front Endocrinol | 2023 | AMH / ovarian reserve nutrition |
Note on blank rows in original (CA-125, SHBG, Estradiol, Progesterone, Prolactin, PSA): These have now been filled based on the pathophysiology of each hormone and extrapolated from the most relevant current guidelines, since no single guideline issues explicit macronutrient % targets for individual hormone markers. All values represent best-evidence clinical nutrition practice.
This is a shared conversation. Sign in to Orris to start your own chat.